Zyspan 600mg Tablets

Description

Indications

Zyspan 600mg Tablets is primarily indicated in conditions like Pneumonia, Respiratory tract infections, Severe or recurrent duodenal and gastric ulcertion, Skin infections.

Contraindication

Zyspan 600mg Tablets is contraindicated in conditions like Breast feeding.

Side Effects

The severe or irreversible adverse effects of Zyspan 600mg Tablets, which give rise to further complications include Convulsions, Stevens johnson syndrome, Stevens johnson syndrome, Leucopenia, Pancytopenia, Abnormal liver function, Anaemia, Lactic acidosis. The symptomatic adverse reactions produced by v are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Diarrhea, Fever, Constipation, Insomnia, Tinnitus, Dry mouth, Rashes, Urticaria, Pruritus, Hypotension, Nausea and vomiting, Tongue discoloration, Neuropathy, Dry mouth, dizziness.

Warnings

Zyspan 600mg Tablets should be used with caution in patients with hepatic impairment; renal impairment; pregnancy (use only if potential benefit outweighs risk); monitor full blood count (including platelet count) weekly uless close observation and blood-pressure monitoring possible, avoid in uncontrolled hypertension, phaeocytochroma, carcinoid tumour, thyrotoxicosis, bipolar depression, schizophrenia, or acute confusional states. Monoamine Oxidase Inhibition: Zyspan 600mg Tablets is a reversible, non-selective monoamine oxidase inhibitor (MAOI). Patients should avoid consuming large amounts of tyramine-rich foods (such as mature cheese, yeast extracts, undistilled alcoholic beverages and fermented soya bean products). In addition, Zyspan 600mg Tablets should not be given with another MAOI or within two weeks of stopping another MAOI.Unless close observation and blood-pressure monitoringis possible, avoid in those receiving SSRIs, 5HT1 agonists (triptans), tricyclic antidepressants, sympathomimitics, dopaminergics, buspirone, pethidine and possibly other opiod analgesics.